Kynurenic acid – a new tool in the treatment of hiperhomocysteinemia and its consequences?
Journal Title: Advances in Hygiene and Experimental Medicine - Year 2012, Vol 66, Issue 0
Abstract
Atherosclerosis together with its cardiovascular consequences is the most common and significant cause of death, particularly in highly developed countries. The process of atherogenesis begins as soon as in childhood and depends on classical risk factors. Atherosclerosis also results from a chronic inflammatory-immune process which takes place in the vascular walls. Furthermore, it has been known for a number of years that the development of atherosclerotic lesions is closely connected with the concentration of homocysteine in serum. Homocysteine is a sulfur amino acid originating from methionine. An increased concentration of homocysteine in blood harmfully influences blood vessels, leading to a higher risk of ischemic heart disease and stroke. Since tackling classical atherosclerosis risk factors is not efficient enough when it comes to protecting the cardiovascular system from diseases, new substances possessing anti-atherogenic properties, especially endogenous ones, are sought. Recently, researchers have paid attention to a connection between homocysteine and an endogenous tryptophan derivative, kynurenic acid. Recently, it was revealed that kynurenic acid counteracts the harmful effects of homocysteine on endothelium cells in vitro. The hypothesis assuming homocysteine-kynurenate interplay suggests the existence of a new mechanism of atherogenesis and gives us an opportunity to use this knowledge in both prevention and treatment of cardiovascular diseases.
Authors and Affiliations
Patrycja Nowicka-Stążka, Krzysztof Stążka, Wojciech Dąbrowski, Waldemar Turski, Maria Majdan, Jolanta Parada-Turska
Keywords
Related Articles
- EP ID EP66722
- DOI -
- Views 153
- Downloads 0
Mobilna antybiotykooporność – o rozprzestrzenianiu się genów determinujących oporność bakterii poprzez produkty spożywcze
W ostatnich latach antybiotyki coraz częściej okazują się nieskuteczne w leczeniu infekcji bakteryjnych. Nabywanie antybiotykooporności przez drobnoustroje jest związane z krążącymi w środowisku genami, które ją warunkuj...
Systemic contact dermatitis
Systemic contact dermatitis (SCD) is a skin inflammation occurring in a patient after systemic administration of a hapten, which previously caused an allergic contact skin reaction in the same person. Most frequently, hy...
Czynniki ryzyka rozwoju nowotworów złośliwych skóry u chorych po przeszczepieniu narządów
Nowotwory stały się drugą co do częstości przyczyną zgonów chorych po przeszczepieniu narządów. Wśród wszystkich nowotworów powstających de novo po transplantacji najczęstszymi są nowotwory skóry, z czego aż 95% stanowią...
The current state of research on psychiatric genetics in Poland and the world: A report covering recent years
The aim of this article was to review the results of research carried out in recent years in relation to genetic studies in psychiatry. The authors’ focus is on the selected disorders, with particular emphasis on the rep...
Glucose tolerance disorders during treatment with glucocorticoids in patients with inflammatory diseases of the musculoskeletal system – based on the analysis of data from the literature and own research results
Glucocorticoids are among the most frequently used anti-inflammatory and immunosuppressive drugs. They are widely used in the treatment of numerous autoimmune disorders. However, the treatment with glucocorticoids is con...